Back Back
MM Question & Answer
Expert Answers to Questions on Contemporary Management of Multiple Myeloma

Released: April 22, 2021

Expiration: April 21, 2022

Shaji K. Kumar
Shaji K. Kumar, MD
Thomas G. Martin
Thomas G. Martin, MD
Philippe Moreau
Philippe Moreau, MD
S. Vincent Rajkumar
S. Vincent Rajkumar, MD
Jesús F. San-Miguel
Jesús F. San-Miguel, MD, PhD
Activity Information

Activity

Progress
1
Course Completed

In this episode,  Shaji K. Kumar, MD; Thomas G. Martin, MD; Philippe Moreau, MD; S. Vincent Rajkumar, MD, and Jesús F. San-Miguel, MD, PhD, answer audience questions from a recent Clinical Care Options live webinar on managing multiple myeloma. Topics include:

  • Approaches for managing smoldering multiple myeloma
  • Insights on new strategies for managing newly diagnosed multiple myeloma
  • Incorporating newly approved agents in the frontline and early relapse setting
  • Choosing and sequencing BCMA-targeted therapies
  • Managing patients with refractory multiple myeloma

Presenters:

Shaji K. Kumar, MD
Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Thomas G. Martin, MD
Clinical Professor of Medicine
Associate Director, Myeloma Program
University of California, San Francisco Medical Center
San Francisco, California

Philippe Moreau, MD
Professor of Clinical Hematology
Head, Hematology Department
University Hospital Hôtel-Dieu
Nantes, France

S. Vincent Rajkumar, MD
Edward W. and Betty Knight Scripps Professor of Medicine
Mayo Clinic
Rochester, Minnesota

Jesús F. San-Miguel, MD, PhD
Director of Clinical and Translational Medicine
Universidad de Navarra
Pamplona, Spain